The Patent Finder
US

Combination Steroid and Glucocorticoid Receptor Antagonist Therapy

US 8,829,024 In force
OverviewAssignmentsSources & methods

Term ends Jul 17, 2032 · High confidence

Filed Jan 6, 2012 as application 13/345,242 · Granted Sep 9, 2014
Base term plus 193 days of patent term adjustment (USPTO delay)
Today
20 years from filing
2012 2032
Clock starts
Jan 6, 2012
Term ends
Jul 17, 2032
Granted
Sep 9, 2014
base term patent term adjustment fee events Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
193
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
3 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.

This patent's term runs 193 days past its 20-year base term on prosecution delay. All three maintenance fees are recorded paid; no more fees are due. Confidence: High. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Jan 6, 2012, when this application, 13/345,242, was filedJan 6, 2032High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustment+193 days, USPTO patent term adjustment recordJul 17, 2032High confidence
Terminal disclaimer capNone on recordno cap appliedHigh confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events3 of 3 maintenance fees paidIn forceHigh confidence
Computed term endThe steps above, in orderJul 17, 2032High confidence

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Aug 17, 2012
Reel 28801, frame 190
Corcept Therapeutics IncorporatedBiopharma Secured Debt Fund II Sub, S.AR.LSecurity Agreement
Jul 28, 2014
Reel 33399, frame 651
Belanoff, JoeCorcept Therapeutics, Inc.Assignment of Assignor's Interest
Jul 28, 2014
Reel 33399, frame 764
Lockey, PeterArgentaAssignment of Assignor's Interest
Jul 28, 2014
Reel 33399, frame 817
ArgentaCorcept Therapeutics, Inc.Assignment of Assignor's Interest
Aug 29, 2017
Reel 43708, frame 44
Biopharma Secured Investments II Sub, S.A.R.L.Corcept Therapeutics IncorporatedRelease of Security Interest in Patents at Reel/Frame No. 028801/0190

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited